Compare Amylx Pharmaceuticals Inc (AMLX) vs Enovix Corporation (ENVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Enovix Corporation — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Enovix Corporation trades at $4.88 (market cap $1.06B). The key difference: Amylx Pharmaceuticals Inc is far larger — about 2.5× Enovix Corporation's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals.
| AMLX | ENVX | |
|---|---|---|
Market Cap | $2.64B | $1.06B |
Sector | Health | Technology |
52-Week High | $24.19 | $13.19 |
52-Week Low | $7.82 | $3.68 |
Enterprise Value | $2.39B | $1.07B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Enovix Corporation
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →
